Reported results
- Revenues were $162,000 for the third quarter of 2026 compared to $1.2 million in the same period last year.
- Gross profit was $16,000 for the third quarter of 2026 compared to $1.1 million in the same period last year.
- Net loss was $596,000 for the third quarter of 2026 compared to net income of $351,000 in the same period last year.
- Adjusted EBITDA was $(1.1) million for the third quarter of 2026 compared to Adjusted EBITDA of $0.4 million in the same period last year.
- Gross loss was $260,000 for the nine months ended September 30, 2026, compared to gross profit of $1.3 million in the same period last year.
- Adjusted EBITDA was $(3.2) million for the nine months ended September 30, 2026, compared to Adjusted EBITDA of $(0.8) million in the same period last year.
Notes
The company completed the transfer of its 51% equity interest in HeartCore Luvina Vietnam Company Limited during the third quarter of 2026 and divested Sigmaways, Inc. in June 2026.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-16 (8-K, Item 2.02). Read the original filing on sec.gov.
